Medtronic (NYSE:MDT)
(MDT shares –18.7% since Feb. 19)
“While the expected short-term impact to our financial results is significant, it is consistent with the impact discussion broadly across the medical device industry. Importantly, we are starting to enter the early stages of a global recovery. As hospitals begin to resume broader treatment of non-COVID-19 patients around the world, we expect our business to begin to recover as well. In addition, given the financial strength of the company, we are executing strategies to come out of this pandemic even stronger, attracting and retaining top talent and increasing and innovating the products and services that we offer physicians, patients and healthcare systems to win in the evolving marketplace.”
– Geoff Martha, CEO of Medtronic
Next>>
Medtronic reveals steep COVID-19 financial impact
FDA grants emergency nod to ventilators from Medtronic, other companies
Geoff Martha officially takes over corner office at Medtronic